Madonella Mite (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and levonorgestrel act on estrogen and progesterone receptors, respectively. Together they suppress the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), preventing ovulation. The progestogen also thickens cervical mucus and alters the endometrial lining, creating conditions that hinder fertilization and implantation.

The dosing regimen for Madonella Mite is determined by the prescribing healthcare professional. Typically, the product is taken as one tablet daily at the same time each day, but the exact schedule and duration should follow the prescriber’s instructions and the product’s labeling.

Madonella Mite is contraindicated in pregnancy (Category X) and must not be started or continued by a woman who is pregnant. While limited data exist for breastfeeding, combined oral contraceptives are generally not recommended during lactation without medical guidance, as they may affect milk production.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Madonella Mite. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Madonella Mite contains the standard dose combination of ethinylestradiol and levonorgestrel, which is comparable to many other combined oral contraceptives on the market. Its efficacy, safety profile, and side‑effect spectrum are similar to alternative products, though individual tolerability may vary based on patient‑specific factors such as hormone sensitivity or comorbid conditions.

Store Madonella Mite tablets at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, light and excessive heat, and retain the original packaging until use to maintain product stability.

Madonella Mite is taken orally. The tablet should be swallowed whole with water, preferably at the same time each day. No food restrictions are required, but consistent timing helps maintain steady hormone levels and maximizes contraceptive effectiveness.

Serious risks include venous thromboembolism, pulmonary embolism, stroke, myocardial infarction, severe hypertension, and rare liver tumors. These events are more likely in women with pre‑existing clotting disorders, smokers over 35, or those with uncontrolled hypertension, and require immediate medical attention if symptoms arise.

Madonella Mite should not be used by women who are pregnant, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or who are over 35 and smoke heavily. It is also contraindicated in individuals with known hypersensitivity to either ethinylestradiol or levonorgestrel.